Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute lymphoblastic leukemia (ALL).

被引：0
|
作者：
Thomas, DA
Sarris, A
O'Brien, S
Cortes, J
Giles, FJ
Faderl, S
Keating, MJ
Burge, C
Cabanillas, F
Kantarjian, H
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Inex Pharmaceut Corp, Burnaby, BC, Canada
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4269
引用
收藏
页码：238B / 238B
页数：1
相关论文
共 50 条
  • [41] Phase II Study of the Salvage Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin (INO) for Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
    Sasaki, Koji
    Jabbour, Elias J.
    O'Brien, Susan M.
    Ravandi, Farhad
    Thomas, Deborah A.
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Burger, Jan A.
    Pemmaraju, Naveen
    Alvarado, Yesid
    Daver, Naval G.
    Jain, Nitin
    Konopleva, Marina
    Champlin, Richard E.
    Khouri, Issa F.
    Kebriaei, Partow
    Marin, David
    DiNardo, Courtney D.
    Estrov, Zeev
    Takahashi, Koichi
    Short, Nicholas J.
    Khouri, Maria R.
    Jacob, Jovitta
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2016, 128 (22)
  • [42] Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib
    August, Keith J.
    Guest, Erin M.
    Lewing, Karen
    Hays, J. Allyson
    Gamis, Alan S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (03)
  • [43] Vincristine Sulfate Liposome Injection A Guide to Its Use in Refractory or Relapsed Acute Lymphoblastic Leukemia
    Harrison, Tracy S.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2013, 27 (01) : 69 - 74
  • [44] Vincristine Sulfate Liposome InjectionA Guide to Its Use in Refractory or Relapsed Acute Lymphoblastic Leukemia
    Tracy S. Harrison
    Katherine A. Lyseng-Williamson
    BioDrugs, 2013, 27 : 69 - 74
  • [45] Phase I trial of sphingosomal vincristine (SV, Marqibo®) and dexamethasone in relapsed or refractory acute lymphocytic leukemia (ALL).
    Thomas, Deborah A.
    Kantaijian, Hagop M.
    Heffner, Leonard
    Stock, Wendy
    Garcia-Manero, Guillermo
    Faderl, Stefan
    Ferrajoli, Alessandra
    Giles, Francis
    Wierda, William
    Ravandi-Kashani, Farhad
    Choy, Gavin
    Berk, Gregory I.
    O'Brien, Susan
    BLOOD, 2006, 108 (11) : 214B - 214B
  • [46] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
    Paul, Shilpa
    Rausch, Caitlin R.
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 166 - 175
  • [47] Safety and efficacy of marqibo (vincristine sulfate liposomes injection, OPTISOME™) in for the treatment of adults with relapsed or refractory acute lymphoblastic leukemia (ALL)
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Stock, Wendy
    Heffner, Leonard
    Tredinnick, Alexandra
    Lu, Baio
    Choy, Gavin S.
    Deitcher, Steven R.
    O'Brien, Susan M.
    BLOOD, 2007, 110 (11) : 263A - 263A
  • [48] Phase I study of liposomal daunorubicin (daunoxome) in relapsed and refractory acute myeloid leukemia.
    Lerchenmüller, C
    Büchner, T
    Berdel, WE
    BLOOD, 1999, 94 (10) : 233B - 233B
  • [49] TREATMENT OF PRIMARY REFRACTORY OR RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN CHILDREN
    TESTI, AM
    MOLETI, ML
    GIONA, F
    IORI, AP
    MELONI, G
    MINIERO, R
    PIGNA, M
    AMADORI, S
    MANDELLI, F
    ANNALS OF ONCOLOGY, 1992, 3 (09) : 765 - 767
  • [50] BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study
    Malfona, Francesco
    Tanasi, Ilaria
    Piccini, Matteo
    Papayannidis, Cristina
    Federico, Vincenzo
    Mancini, Valentina
    Roncoroni, Elisa
    Todisco, Elisabetta
    Bianchi, Simona
    Ciotti, Giulia
    Chiusolo, Patrizia
    Gentile, Massimo
    Gianfelici, Valentina
    Giglio, Fabio
    Malagola, Michele
    Mule, Antonino
    Saraceni, Francesco
    Vetro, Calogero
    Zallio, Francesco
    Cappelli, Luca Vincenzo
    Pizzolo, Giovanni
    Foa, Robin
    Bonifacio, Massimiliano
    Chiaretti, Sabina
    HAEMATOLOGICA, 2024, 109 (03) : 988 - 993
12345